215 related articles for article (PubMed ID: 37321026)
1. An Updated Meta-Analysis on the Clinical Outcomes of Percutaneous Left Atrial Appendage Closure Versus Direct Oral Anticoagulation in Patients With Atrial Fibrillation.
Jiang H; Koh TH; Vengkat V; Fei G; Ding ZP; Ewe SH; Jappar I; Lim ST; Yap J
Am J Cardiol; 2023 Aug; 200():135-143. PubMed ID: 37321026
[TBL] [Abstract][Full Text] [Related]
2. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
[TBL] [Abstract][Full Text] [Related]
3. Severity of Ischemic Stroke After Left Atrial Appendage Closure vs Nonwarfarin Oral Anticoagulants.
Turagam MK; Kawamura I; Neuzil P; Nair D; Doshi S; Valderrabano M; Hala P; Della Rocca D; Gibson D; Funasako M; Ha G; Lee B; Musikantow D; Yoo D; Flautt T; Dukkipati S; Natale A; Gurol ME; Halperin J; Mansour M; Reddy VY
JACC Clin Electrophysiol; 2024 Feb; 10(2):270-283. PubMed ID: 37999669
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials.
Sahay S; Nombela-Franco L; Rodes-Cabau J; Jimenez-Quevedo P; Salinas P; Biagioni C; Nuñez-Gil I; Gonzalo N; de Agustín JA; Del Trigo M; Perez de Isla L; Fernández-Ortiz A; Escaned J; Macaya C
Heart; 2017 Jan; 103(2):139-147. PubMed ID: 27587437
[TBL] [Abstract][Full Text] [Related]
5. 4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation.
Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
J Am Coll Cardiol; 2022 Jan; 79(1):1-14. PubMed ID: 34748929
[TBL] [Abstract][Full Text] [Related]
6. Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation.
Kar S; Doshi SK; Alkhouli M; Camm AJ; Coylewright M; Gibson MC; Granger CB; Gurol ME; Huber K; Mansour M; Nair DG; Natale A; Pocock SJ; Reddy VR; Saliba W; Christen T; Allocco DJ; Ellenbogen KA; Leon MB
Am Heart J; 2023 Oct; 264():123-132. PubMed ID: 37279840
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of left atrial appendage closure with Watchman for non-valvular atrial fibrillation patients in Japan.
Kamae I; Zhong Y; Hara H; Inoue K; Yasaka M; Reddy VY; Holmes DR; Sakurai M; Gavaghan MB; Amorosi SL; McGovern AM; Priest V; Inoue S; Shibahara H; Akehurst RL
J Med Econ; 2023; 26(1):1357-1367. PubMed ID: 37819734
[TBL] [Abstract][Full Text] [Related]
8. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
[TBL] [Abstract][Full Text] [Related]
9. Latest outcomes of transcatheter left atrial appendage closure devices and direct oral anticoagulant therapy in patients with atrial fibrillation over the past 5 years: a systematic review and meta-analysis.
Takeda K; Tsuboko Y; Iwasaki K
Cardiovasc Interv Ther; 2022 Oct; 37(4):725-738. PubMed ID: 35098478
[TBL] [Abstract][Full Text] [Related]
10. Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis.
Holmes DR; Doshi SK; Kar S; Price MJ; Sanchez JM; Sievert H; Valderrabano M; Reddy VY
J Am Coll Cardiol; 2015 Jun; 65(24):2614-2623. PubMed ID: 26088300
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke: A propensity-score matched study.
Korsholm K; Valentin JB; Damgaard D; Diener HC; Camm AJ; Landmesser U; Hildick-Smith D; Johnsen SP; Nielsen-Kudsk JE
Int J Cardiol; 2022 Sep; 363():56-63. PubMed ID: 35780932
[TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study.
Durand M; Schnitzer ME; Pang M; Carney G; Eltonsy S; Filion KB; Fisher A; Jun M; Kuo IF; Renoux C; Paterson JM; Quail J; Matteau A;
CMAJ Open; 2020; 8(4):E877-E886. PubMed ID: 33355273
[TBL] [Abstract][Full Text] [Related]
13. Left Atrial Appendage Closure Versus Oral Anticoagulation in Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Al-Abcha A; Saleh Y; Elsayed M; Elshafie A; Herzallah K; Baloch ZQ; Banga S; Rayamajhi S; Abela GS
Cardiovasc Revasc Med; 2022 Mar; 36():18-24. PubMed ID: 33903038
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Left Atrial Appendage Closure and Oral Anticoagulation After Atrial Fibrillation Catheter Ablation.
Fei ZT; Yao PC; Qiu JH; Chen M; Fei YD; Li W; Zhang PP; Sun J; Wang QS; Li YG
Am J Cardiol; 2023 Oct; 204():312-319. PubMed ID: 37567023
[TBL] [Abstract][Full Text] [Related]
15. Net Clinical Benefit of Left Atrial Appendage Closure Versus Warfarin in Patients With Atrial Fibrillation: A Pooled Analysis of the Randomized PROTECT-AF and PREVAIL Studies.
Brouwer TF; Whang W; Kuroki K; Halperin JL; Reddy VY
J Am Heart Assoc; 2019 Dec; 8(23):e013525. PubMed ID: 31752643
[TBL] [Abstract][Full Text] [Related]
16. Short-term antiplatelet versus anticoagulant therapy after left atrial appendage closure: a systematic review and meta-analysis.
Zhou Q; Liu X; Gu ZC; Yang X; Huang XH; Wu YZ; Tao YY; Wei M
J Thromb Thrombolysis; 2024 Feb; 57(2):194-203. PubMed ID: 38180590
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous left atrial appendage closure in patients with primary hemostasis disorders and atrial fibrillation.
Dognin N; Salaun E; Champagne C; Domain G; O'Hara G; Philippon F; Paradis JM; Faroux L; Beaudoin J; O'Connor K; Bernier M; Rodés-Cabau J; Champagne J
J Interv Card Electrophysiol; 2022 Aug; 64(2):497-509. PubMed ID: 34822043
[TBL] [Abstract][Full Text] [Related]
18. Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex.
Carnicelli AP; Hong H; Connolly SJ; Eikelboom J; Giugliano RP; Morrow DA; Patel MR; Wallentin L; Alexander JH; Cecilia Bahit M; Benz AP; Bohula EA; Chao TF; Dyal L; Ezekowitz M; A A Fox K; Gencer B; Halperin JL; Hijazi Z; Hohnloser SH; Hua K; Hylek E; Toda Kato E; Kuder J; Lopes RD; Mahaffey KW; Oldgren J; Piccini JP; Ruff CT; Steffel J; Wojdyla D; Granger CB;
Circulation; 2022 Jan; 145(4):242-255. PubMed ID: 34985309
[TBL] [Abstract][Full Text] [Related]
19. Stroke prevention of thoracoscopic left atrial appendage clipping in patients with non-valvular atrial fibrillation at high risk of stroke and bleeding: study protocol for a non-randomised controlled clinical trial.
Ye C; Han X; Chen Y; Liu F; Ma H; Yang Y; Liu Y; Hu Q; Yao Q; Xie W; Xu D
BMJ Open; 2022 Oct; 12(10):e063931. PubMed ID: 36307161
[TBL] [Abstract][Full Text] [Related]
20. Effect of Glomerular Filtration Rates on Outcomes Following Percutaneous Left Atrial Appendage Closure.
Faroux L; Cruz-González I; Arzamendi D; Freixa X; Nombela-Franco L; Peral V; Caneiro-Queija B; Mangieri A; Trejo-Velasco B; Asmarats L; Regueiro A; McInerney A; Mas-Lladó C; Estevez-Loureiro R; Laricchia A; O'Hara G; Rodés-Cabau J
Am J Cardiol; 2021 Apr; 145():77-84. PubMed ID: 33508268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
